2025-08-28 22:57:13
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Syncom Formulations India Ltd Q4 FY2022 profit at Rs. 4 crores
Posted On : 2022-05-18 22:17:56( TIMEZONE : IST )
SYNCOM FORMULATIONS (INDIA) LTD. has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 63.9326 crores during the period ended March 31, 2022 as compared to Rs. 59.4614 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 4.0032 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 5.7616 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 0.05 for the period ended March 31, 2022 as compared to Rs. 0.07 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 63.9326 crs | ₹59.4614 crs |  7.52% |
| Net Profit | ₹4.0032 crs | ₹5.7616 crs |  -30.52% |
| EPS | ₹0.05 | ₹0.07 | -28.57% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 63.9326 crores during the period ended March 31, 2022 as compared to Rs.69.2735 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.4.0032 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.7.0745 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.0.05 for the period ended March 31, 2022 as compared to Rs.0.09 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 63.9326 crs | ₹69.2735 crs | -7.71% |
| Net Profit | ₹4.0032 crs | ₹7.0745 crs | -43.41% |
| EPS | ₹0.05 | ₹0.09 | -44.44% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.231.6557 crores during the Financial Year ended March 31, 2022 as compared to Rs.251.9461 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.21.0075 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.29.8278 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.0.24 for the Financial Year ended March 31, 2022 as compared to Rs.0.38 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹231.6557 crs | ₹251.9461 crs | -8.05% |
| Net Profit | ₹21.0075 crs | ₹29.8278 crs | -29.57% |
| EPS | ₹0.24 | ₹0.38 | -36.84% |
Shares of SYNCOM FORMULATIONS (INDIA) LTD. was last trading in BSE at Rs. 10.05 as compared to the previous close of Rs. 10.24. The total number of shares traded during the day was 1371688 in over 3764 trades.
The stock hit an intraday high of Rs. 10.47 and intraday low of 10.00. The net turnover during the day was Rs. 13936858.00.
